InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,298.00
(
0.00%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
73.74
(
-0.20%
)
Bitcoin
63,292.92
(
-0.52%
)
Post# of 253197
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120480
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jmkobers post# 224175

Tuesday, 03/19/2019 11:12:18 AM

Tuesday, March 19, 2019 11:12:18 AM

Post# of 253197
The RT002 FDA label for glabellar lines might have the K-M analysis from the SAKURA studies without an explicitly specified range for duration; if the label does have an explicitly specified range, “approximately 4-6 months” would be sufficient to establish product differentiation from all other toxins. Anything better than that would be icing on the cake.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up